 DPT-IPV vaccine in Japan | |
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Inactivated poliovirus vaccine | Vaccine |
| Clinical data | |
| Trade names | Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others |
| Other names | diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) |
| AHFS/Drugs.com | KinrixQuadracel |
| Pregnancy category |
|
| Routes of administration | Intramuscular injection |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
DTaP-IPV vaccine is acombination vaccine whose full generic name is diphtheria and tetanustoxoids andacellular pertussis adsorbed andinactivated poliovirus vaccine (IPV).[1][2]
It is also known asDTaP/IPV,dTaP/IPV, DTPa-IPV, orDPT-IPV.[1] It protects against theinfectious diseasesdiphtheria,tetanus,pertussis, andpoliomyelitis.[1]
Branded formulations marketed in the USA areKinrix fromGlaxoSmithKline[3] andQuadracel fromSanofi Pasteur.[4]
Repevax is available in the UK.[5][6]
In Japan, the formulation is called 四種混合(shishukongou - "mixture of 4").Astellas markets it under the クアトロバック ('Quattro-back') formulation, while another is available fromMitsubishi Tanabe Pharma named テトラビック ('Tetrabic').[7][8]A previous product byTakeda Pharmaceutical Company has been withdrawn by the company.[9]
 | This article aboutvaccines orvaccination is astub. You can help Wikipedia byexpanding it. |
